US Consumer Sentiment Remains Pessimistic Economic Outlook Uncertain Amidst Inflation Geopolitical Tensions and Trade Policy Amazon Reports Record Thanksgiving Holiday Week Sales and Item Volume Government Unveils Plan to Revamp Tax Administration for Seamless GST Implementation Home Depot Comparable Sales Catch Up to Lowes Potentially Paving Way for Stock Performance Should a 62YearOld Claim Social Security Now and Switch to Survivors Benefit at 67 A BreakEven Analysis Nationwide Faces Governance Concerns as Labour MP Calls for Reform Ahead of AGM ACHC Q1 2026 Earnings Strong EPS Beat Amid Operational Improvements KALA Q4 2025 Earnings Loss Narrows Sharply on Disciplined Cost Management MCBS Q1 2026 Earnings Solid EPS Beat Amid Slight Stock Pullback Centerra Gold Q1 2026 Earnings EPS Misses Estimates Amid Operational Pressures Diamondrock Hospitality DRH Q1 2026 Earnings EPS Surges Past Estimates Despite Undisclosed Revenue ConAgra Brands CAG Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain Baxter International BAX Edges Higher as Stock Consolidates Near Key Resistance Horizon Space Acquisition II HSPT Surges 1674 Speculative Interest or Fundamental Catalyst Hain Celestial Stock Surges 10 as Shares Break Above Key Moving Averages Robinhood Ventures Fund I RVI Tumbles 834 Key Support Levels in Focus Osprey Bitcoin Trust OBTC Holds Steady Near Key Resistance Amid Cryptocurrency Tailwinds Pine Labs Shares Slip on Q4 Earnings Miss Amid Middle East Headwinds ALMS Q1 2026 Earnings NarrowerthanExpected Loss and Pipeline Progress Inovio Pharmaceuticals INO Holds Near Support Amid Slight Decline Johnson Johnson JNJ Dips 107 as Defensive Stock Tests Key Support Levels Bank OZK OZK Edges Lower as Shares Trade in Tight Range Support at 4574 Holds Lithia Motors LAD Gains 264 as Stock Approaches Key Resistance Level Constellium CSTM Rallies 3 Approaching Key Resistance at 3673 Aebi Schmidt Holding AG AEBI Edges Higher as Shares Climb Over 2 Key Levels in Focus Flushing Financial Stock Slips as Resistance Holds Firm Ernexa Therapeutics ERNA Slips 38 as Shares Test Key Support Near 1139